Orchestra BioMed Holdings annual total assets
2020
2021
2022
2023
2024
2025
Orchestra BioMed Holdings Total Assets Growth & History (OBIO)
Orchestra BioMed Holdings's total assets was $114.9M for fiscal 2025.
View full Orchestra BioMed Holdings company overviewOrchestra BioMed Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $114.9M | $38.7M | +50.78% |
| 2024 | 2024-12-31 | $76.2M | −$19.0M | −20.00% |
| 2023 | 2023-12-31 | $95.2M | −$360,000 | −0.38% |
| 2022 | 2022-12-31 | $95.6M | −$66.3M | −40.94% |
| 2021 | 2021-12-31 | $161.8M | −$332,170 | −0.20% |
| 2020 | 2020-12-31 | $162.2M | — | — |
Orchestra BioMed Holdings quarterly total assets
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $115.7M | $72.9M | +170.17% |
| Q1 2026 | 2026-03-31 | $100.7M | $41.6M | +70.46% |
| Q4 2025 | 2025-12-31 | $114.9M | $38.7M | +50.78% |
| Q3 2025 | 2025-09-30 | $104.8M | $29.5M | +39.15% |
| Q2 2025 | 2025-06-30 | $42.8M | −$29.6M | −40.84% |
| Q1 2025 | 2025-03-31 | $59.1M | −$23.6M | −28.53% |
| Q4 2024 | 2024-12-31 | $76.2M | −$19.0M | −20.00% |
| Q3 2024 | 2024-09-30 | $75.3M | −$41.0M | −35.27% |
| Q2 2024 | 2024-06-30 | $72.4M | −$53.5M | −42.50% |
| Q1 2024 | 2024-03-31 | $82.6M | −$53.7M | −39.37% |
| Q4 2023 | 2023-12-31 | $95.2M | −$360,000 | −0.38% |
| Q3 2023 | 2023-09-30 | $116.4M | $47.7M | +69.50% |
| Q2 2023 | 2023-06-30 | $125.9M | −$35.7M | −22.09% |
| Q1 2023 | 2023-03-31 | $136.3M | −$25.2M | −15.63% |
| Q4 2022 | 2022-12-31 | $95.6M | −$66.3M | −40.94% |
| Q3 2022 | 2022-09-30 | $68.6M | −$93.2M | −57.59% |
| Q2 2022 | 2022-06-30 | $161.6M | −$448,268 | −0.28% |
| Q1 2022 | 2022-03-31 | $161.5M | −$576,368 | −0.36% |
| Q4 2021 | 2021-12-31 | $161.8M | −$332,170 | −0.20% |
| Q3 2021 | 2021-09-30 | $161.9M | −$317,472 | −0.20% |
| Q2 2021 | 2021-06-30 | $162.0M | — | — |
| Q1 2021 | 2021-03-31 | $162.1M | — | — |
| Q4 2020 | 2020-12-31 | $162.2M | — | — |
| Q3 2020 | 2020-09-30 | $162.2M | — | — |
Orchestra BioMed Holdings total assets trends
Over the last five fiscal years, Orchestra BioMed Holdings's total assets decreased from $162.2M to $114.9M, a change of −$47.3M. The latest reported quarter, Q2 2026, shows $115.7M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orchestra BioMed Holdings source filings ↗